Chemical and Analytical Strategies for Biosimilars

Biosimilar products are required by regulatory authorities to have appropriate and comparable quality, safety and efficacy with a reference biologic product .Analysis of biosimilars and biologics structures to be a standout amongst the most critical angle towards the biologics and biosimilar advancement process. Bio-analytical strategies for process advancement and approval and also utilization of generation innovations, for example, disposables and store network co-ordinations can enable organizations to build up office adaptability. This biosimilars worldwide occasion additionally incorporates Bio-analytical strategies, Formulation, Bioassay for equivalence and power testing, GMP protein examination, LC/MS investigation for revelation, preclinical, and clinical projects. While small changes in these parameters can impact the various chemical permutations for a given biotherapeutic, innovators can, under certain circumstances, change the host cell, fermentation process, purification process, and even manufacturing site, but the product can be validated without undertaking a complete new product development review.

  • Biochemical and Biosimilars Characterization
  • Biosimilars multimodal techniques
  • Biosimilars bio analytical methods
  • Bioassays for comparability and potency testing
  • LC/MS analysis for discovery, preclinical and clinical programs
  • Biosimilars GMP protein analysis
  • Biosimilars electrophoresis

Related Conference of Chemical and Analytical Strategies for Biosimilars

November 27-27, 2021

Drug Formulation Bioavailability 2021

London, UK
February 07-08, 2022

World Congress on Pharmaceutical Chemistry

Paris, France

Chemical and Analytical Strategies for Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in